Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications

OBJECTIVE: To evaluate the cost-effectiveness of a genetic testing policy for HNF1A-, HNF4A-, and GCK-MODY in a hypothetical cohort of type 2 diabetic patients 25–40 years old with a MODY prevalence of 2%. RESEARCH DESIGN AND METHODS: We used a simulation model of type 2 diabetes complications based...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Naylor, Rochelle N., John, Priya M., Winn, Aaron N., Carmody, David, Greeley, Siri Atma W., Philipson, Louis H., Bell, Graeme I., Huang, Elbert S.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2014
Matèries:
Epidemiology/Health Services Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3867988/
https://ncbi.nlm.nih.gov/pubmed/24026547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc13-0410
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars